Etelcalcetide Inhibits the Progression of Left Atrial Volume Index Compared to Alfacalcidol in Hemodialysis Patients

INTRODUCTION: Increased left atrial (LA) size is a risk factor for cardiovascular events and all-cause mortality. It is closely related to left ventricular hypertrophy and chronic volume overload, both of which are common in hemodialysis. Calcimimetic treatment with etelcalcetide (ETL) previously sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörr, Katharina, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Marculescu, Rodrig, Beitzke, Dietrich, Hödlmoser, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664324/
https://www.ncbi.nlm.nih.gov/pubmed/37729887
http://dx.doi.org/10.1159/000533899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664324/
https://www.ncbi.nlm.nih.gov/pubmed/37729887
http://dx.doi.org/10.1159/000533899

Ejemplares similares